GENECAPS

Serial Number 97373693
733

Registration Progress

Application Filed
Apr 21, 2022
Under Examination
Dec 19, 2023
Approved for Publication
Oct 24, 2023
Published for Opposition
Oct 24, 2023
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jun 19, 2026 171 days

Trademark Image

GENECAPS

Basic Information

Serial Number
97373693
Filing Date
April 21, 2022
Published for Opposition
October 24, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Nov 19, 2025
Application
Pending
Classes
005

Rights Holder

CSL Behring Gene Therapy, Inc.

03
Address
35 N. Lake Avenue, Suite 650
Pasadena, CA 91101

Ownership History

CSL Behring Gene Therapy, Inc.

Original Applicant
03
Pasadena, CA

CSL Behring Gene Therapy, Inc.

Owner at Publication
03
Pasadena, CA

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

Next Deadline
171 days remaining
NOA E-Mailed - SOU Required
Due Date
June 19, 2026
Extension Available
Until December 19, 2026

Application History

36 events
Date Code Type Description Documents
Nov 20, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 19, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 19, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 19, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 20, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 20, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 19, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
May 19, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 15, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 19, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 15, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 19, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 16, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 15, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 15, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
May 15, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 19, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 24, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 18, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 22, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 22, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 22, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 22, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
May 22, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Feb 22, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 22, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 22, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 8, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 27, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 27, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 27, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 27, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 25, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Non-viral vectors in the form of nanoscale matrices, namely, pharmaceutical preparations for the delivery of therapeutic agents for the treatment or prevention of diseases affecting the immune system or hematologic system; Non-viral vectors, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Additional Information

Pseudo Mark
GENE CAPS

Classification

International Classes
005